R L Rubin
Overview
Explore the profile of R L Rubin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rubin R, Haluptzok R, Davila L
Lupus
. 2020 Feb;
29(5):509-513.
PMID: 32041503
Despite its long history of untoward side effects of a systemic autoimmune disease, drug-induced lupus can be difficult to recognize because of the disconnect between chronic drug usage and onset...
2.
Rubin R, Teodorescu M, BEUTNER E, Plunkett R
Lupus
. 2004 Jun;
13(4):249-56.
PMID: 15176661
The immunofluorescence antinuclear antibody (ANA) test has been widely used to monitor autoimmune disease, but its value for diagnostic purposes is compromised by low specificity and high prevalence in disease-free...
3.
Teodorescu M, Ustiyan V, Russo K, Rubin R
Clin Immunol
. 2004 Mar;
110(2):145-53.
PMID: 15003811
The mechanism of attachment of circulating immune complexes (CIC) to glomerular basement membranes (GBM) in systemic lupus erythematosus (SLE) has not yet been elucidated. One difficulty is that CIC must...
4.
Schett G, Smole J, Zimmermann C, Hiesberger H, Hoefler E, Fournel S, et al.
Lupus
. 2002 Dec;
11(11):704-15.
PMID: 12475000
This study investigates specificity, sensitivity and concomitant presence of antibodies against histone H1 (H1), nucleosomes (NUC), chromatin (CHR) and dsDNA in patients with systemic lupus erythematosus (SLE), analyses their association...
5.
Rubin R, Salomon D, Guerrero R
Lupus
. 2002 Jan;
10(11):795-801.
PMID: 11789489
Autoimmunity develops when a lupus-inducing drug is introduced into the thymus of normal mice, but the relevance of this model to the human disorder is unclear in part because it...
6.
Rubin R, Kretz-Rommel A
Crit Rev Immunol
. 2001 Oct;
21(1-3):29-40.
PMID: 11642611
To be positively selected, immature thymocytes must receive signaling through their T-cell receptor (TCR), and engagement of relatively low-affinity self-peptides permits further T-cell maturation. However, mature T cells no longer...
7.
Kretz-Rommel A, Rubin R
Cell Immunol
. 2001 May;
208(2):125-36.
PMID: 11333145
In vivo exposure of the thymus of normal mice to procainamide-hydroxylamine, a lupus-inducing drug, causes development of chromatin-reactive T cells. Autoantibodies subsequently appear, but their origin and significance are unknown....
8.
Rubin R, Kretz-Rommel A
Curr Opin Hematol
. 2001 Jan;
8(1):34-40.
PMID: 11138624
The drug-metabolizing capacity of the liver is well known but cannot account for most idiosyncratic adverse drug reactions. Of the extrahepatic sources of reactive drug metabolites, the neutrophil has received...
9.
Kretz-Rommel A, Rubin R
Nat Med
. 2000 Mar;
6(3):298-305.
PMID: 10700232
To differentiate into T cells, immature thymocytes must engage, through their antigen-specific T-cell receptor, peptides derived from self proteins presented by cortical epithelial cells in the thymus, a process called...
10.
Schett G, Rubin R, Steiner G, Hiesberger H, Muller S, Smolen J
Arthritis Rheum
. 2000 Feb;
43(2):420-8.
PMID: 10693884
Objective: To compare and investigate antihistone and antichromatin antibody responses as well as clinical variables in patients with systemic lupus erythematosus (SLE) who were either positive (LEC+) or negative (LEC-)...